DSM Aborts Sale of Special Products to Arsenal

DSM says it has decided not to proceed with a previously announced sale of its DSM Special Products (DSP) business to Arsenal Capital Partners. This follows an in-depth investigation by the European Commission into the transaction and the conditions imposed, which made the sale "no longer feasible," DSM says. DSP has annual sales of about €100 million ($128.2 million) and employs 130 people at its Rotterdam and Sittard, the Netherlands sites. It makes Purox, an ingredient used in food as well as in a range of industrial applications. It also...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers